5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.13▼ | 8.20▼ | 8.19▼ | 8.23▼ | 8.74▼ |
MA10 | 8.16▼ | 8.19▼ | 8.19▼ | 8.30▼ | 7.47▲ |
MA20 | 8.20▼ | 8.19▼ | 8.26▼ | 9.01▼ | 5.73▲ |
MA50 | 8.18▼ | 8.26▼ | 8.14▼ | 7.27▲ | 9.00▼ |
MA100 | 8.24▼ | 8.14▼ | 8.80▼ | 5.62▲ | 13.61▼ |
MA200 | 8.22▼ | 8.91▼ | 8.44▼ | 7.44▲ | 24.72▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.012▼ | -0.001▼ | -0.014▼ | -0.253▼ | 0.664▲ |
RSI | 36.832▼ | 43.557▼ | 44.157▼ | 49.199▼ | 55.955▲ |
STOCH | 11.382▼ | 63.409 | 53.327 | 24.850 | 72.005 |
WILL %R | -88.889▼ | -59.574 | -68.333 | -81.848▼ | -34.424 |
CCI | -118.498▼ | -73.033 | -108.347▼ | -62.553 | 66.975 |
Thursday, June 08, 2023 03:13 AM
The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and ...
|
Wednesday, June 07, 2023 07:01 PM
Fintel reports that on June 7, 2023, Canaccord Genuity reiterated coverage of Y-Mabs Therapeutics (NASDAQ:YMAB) with a Buy recommendation. Analyst Price Forecast Suggests 58.93% Upside As of June 2, ...
|
Wednesday, June 07, 2023 11:00 AM
Over the past 3 months, 7 analysts have published their opinion on Y-mAbs Therapeutics (NASDAQ:YMAB) stock. These analysts are typically employed by large Wall Street banks and tasked with ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/06/23 | 8.02 | 8.39 | 7.92 | 8.11 | 154,019 |
07/06/23 | 8.43 | 8.59 | 8.09 | 8.16 | 228,795 |
06/06/23 | 8.26 | 8.46 | 8.05 | 8.45 | 283,486 |
05/06/23 | 8.02 | 8.42 | 7.92 | 8.24 | 191,609 |
02/06/23 | 7.92 | 8.18 | 7.56 | 8.17 | 265,653 |
01/06/23 | 8.08 | 8.08 | 7.67 | 7.78 | 290,421 |
31/05/23 | 8.36 | 8.815 | 8.06 | 8.13 | 355,459 |
30/05/23 | 8.67 | 9.055 | 7.80 | 8.28 | 359,306 |
26/05/23 | 9.00 | 9.23 | 8.64 | 8.70 | 242,514 |
25/05/23 | 9.66 | 9.71 | 8.98 | 9.00 | 294,430 |
|
|
||||
|
|
||||
|
|